Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

hepatitis A vaccine

hepatitis A vaccine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Vaqta Pediatric SUSPENSION, INTRAMUSCULAR 25 units/0.5 mL    
Vaqta SUSPENSION, INTRAMUSCULAR 50 units/mL    
Havrix Pediatric SUSPENSION, INTRAMUSCULAR 720 units/0.5 mL      
Havrix SUSPENSION, INTRAMUSCULAR 1440 units/mL preservative free      
VIEW MORE Vaccines
CLASS
801200
Comments:

As of June 2023, utilize HAVRIX for both adult and pediatric patients.

HAVRIX 1440 units/mL , HAVRIX 720 units/0.5 mL

 

 

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

hepatitis A adult vaccine (Vaqta)

  • 50 units/mL suspension intramuscular

hepatitis A adult vaccine (Havrix)

  • 1440 units/mL suspension intramuscular

 

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

hepatitis A pediatric vaccine (Vaqta)

  • 25 units/0.5 mL suspension intramuscular

hepatitis A pediatric vaccine (Havrix)

  • 720 units/0.5 mL suspension intramuscular

 

 

Reviewed: January 22, 2008 and January 28, 2014

Updated: June 22, 2018 (GSK Contract), June 2023 (GSK Contract)

Last updated: Jun. 30, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved